Results 171 to 180 of about 77,929 (279)

Difficult Airway Management in a Conscious Patient With Ankylosing Spondylitis: A Case Report. [PDF]

Cureus
Carvalho L, Santos J, Gonçalves L, Valente E.   +3 more
europepmc   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 10 No. 2 [PDF]

, 1974

core   +1 more source

Certolizumab Pegol Reduced Anterior Uveitis Flares Compared With Standard Non‐Biologic Treatment: Results From an Overlap Weighting Analysis in High‐Risk Patients With Axial Spondyloarthritis

International Journal of Rheumatic Diseases, Volume 29, Issue 4, April 2026.
ABSTRACT Objective Acute anterior uveitis (AAU) is the most common extra‐musculoskeletal manifestation of axial spondyloarthritis (axSpA). This study compared the effect of the tumor necrosis factor inhibitor (TNFi) certolizumab pegol (CZP) with standard non‐biologic care, on AAU flare rate in patients with axSpA and high risk of recurrent uveitis ...
Nigil Haroon, Zeynep Baskurt, Tina Chim, Robert D. Inman, Thomas Kumke, Rachel Tham, Mindy Kim, Irene van der Horst‐Bruinsma, Lianne S. Gensler   +8 more
wiley   +1 more source

Rituximab for the treatment of membranous nephropathy in a patient with ankylosing spondylitis: a case report. [PDF]

Front Med (Lausanne)
Zhong R, Su L, Li H, Zhu H, Xiao Z.
europepmc   +1 more source

Risk stratification using coronary artery calcium and potential benefit of semaglutide therapy: A cost‐effectiveness modelling study

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 3229-3237, April 2026.
Abstract Aim Coronary artery calcium (CAC) scoring is observed to improve risk stratification for major adverse cardiovascular events (MACE). Semaglutide, a recently introduced anti‐obesity drug, is very effective, but wider use is limited due to high costs.
Sai Rahul Ponnana, Tong Zhang, Santosh Kumar Sirasapalli, Zhuo Chen, Jean‐Eudes Dazard, Niketh Surya, Shamsa Elhussain, Kanimozhi Sivanantham, Robert Okyere, Ian J. Neeland, Sanjay Rajagopalan, Salil V. Deo   +11 more
wiley   +1 more source

Population pharmacokinetics of tofacitinib in patients with active ankylosing spondylitis. [PDF]

Int J Clin Pharmacol Ther
Tsuchiwata S, Suzuki A, Wang Q, Kanik K, Fallon L, Menon S.   +5 more
europepmc   +1 more source

Evaluating Associations Between Ankylosing Spondylitis, Torque Teno Virus and Polymorphisms in Interleukin 6 and Vitamin D Receptor Genes

International Journal of Immunogenetics, Volume 53, Issue 2, Page 157-170, April 2026.
ABSTRACT The etiology of ankylosing spondylitis (AS) is complex and not yet fully understood. Interleukin‐6 (IL‐6), vitamin D and the vitamin D receptor (VDR) play an important role in modulating immune response, and Torque teno virus is considered a marker of immune status. This case–control study aimed to investigate the predisposition to AS. A total
Dănuț Cimponeriu, Lavinia‐Mariana Berca, Irina Radu, Mihai Toma, Remus Nica, Silvia Nica, Roxana Măciucă   +6 more
wiley   +1 more source

Deformity Correction in Ankylosing Spondylitis with Cervical Fracture: A Case Report. [PDF]

J Orthop Case Rep
Rout JK, Kaushik S, Tyagi A.
europepmc   +1 more source

Epidemiology and Genetics of Rheumatic Diseases Suggest a Constant Rate of DNA Damage as Underlying Cause

Immunology, Volume 177, Issue 4, Page 736-748, April 2026.
A constant rate of DNA damage that is not perfectly repaired will cause a constant rate of DNA mutations. The chance of mutation will increase if DNA is prone to damage, such as occurs in somatic hypermutation (SHM) hotspots and GC‐rich DNA. Thus, if one mutation‐prone DNA site drives disease, the age of onset of disease and degree of penetrance should
Piet C. de Groen
wiley   +1 more source

Overlap Syndrome of Ankylosing Spondylitis and Mixed Connective Tissue Disease in a Male Patient. [PDF]

Cureus
Kada S, Ait Malek S, Mariam E, Ghozlani I.   +3 more
europepmc   +1 more source